3 weeks ago

Aurobindo Pharma Q1 profit up 25%, record ₹9,150 crore revenue

Aurobindo Pharma Q1 profit up 25%, record ₹9,150 crore revenue
Aurobindo Pharma Q1 profit rises 25% as revenue hits record ₹9,150 crore · thehindubusinessline.com

A big medicine-making company called Aurobindo Pharma shared how it did in the first three months of its new business year.

The company made more money than it did at the same time last year.

Its profit, which is the money left after paying costs, went up by 25 percent.

The total money the company earned from selling medicines was the highest it has ever made in one three-month period.

That amount was 9,150 crore rupees, which is a very large number.

The growth happened because the company did well in almost all the kinds of business it does.

The company is based in the city of Hyderabad in India.

Its leader, K. Nithyananda Reddy, said they began the new financial year with strong results.

He said their careful work and many different products will help them keep growing in the future.

Key facts

Company
Aurobindo Pharma
Headquarters
Hyderabad
Quarter
Q1 FY27 (ended June 30, 2026)
Net Profit
₹1,032 crore (up 25%)
Previous Year Net Profit
₹824 crore
Revenue
₹9,150 crore (record, up 16%)
Previous Year Revenue
₹7,868 crore
Vice-Chairman & MD
K. Nithyananda Reddy

Quotes

K. Nithyananda Reddy

Vice‑Chairman and Managing Director of Aurobindo Pharma

“While the global operating environment remains dynamic, our resilient business model, expanding capabilities, and strategic investments position us well to achieve our long‑term growth objectives and create sustained value for our stakeholders.”
thehindubusinessline.com
“We have commenced FY27 on a strong note, delivering healthy growth across our businesses through disciplined execution, operational excellence, and the continued strength of our diversified product portfolio.”
thehindubusinessline.com

Sources

Related news